Nicotine and Levemir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nicotine (nicotine) and Levemir (insulin detemir recombinant). Common drug interactions include grand mal convulsion among females and diabetes mellitus inadequate control among males.

The phase IV clinical study analyzes what interactions people have when they take Nicotine and Levemir. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Nicotine?

Nicotine has active ingredients of nicotine. It is often used in quit smoking. eHealthMe is studying from 20,443 Nicotine users. Check the latest studies of Nicotine.

What is Levemir?

Levemir has active ingredients of insulin detemir recombinant. It is often used in diabetes. eHealthMe is studying from 13,850 Levemir users. Check the latest studies of Levemir.



On Jul, 15, 2026

13 people who take Nicotine and Levemir together, and have interactions are studied.

Nicotine and Levemir drug interactions.

What are the common drug interactions of Nicotine and Levemir, by gender? *:

female:

  1. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  2. Hyperlipidaemia (presence of excess lipids in the blood)
  3. Hypertension (high blood pressure)
  4. Neuropathy peripheral (surface nerve damage)
  5. Oral candidiasis (fungal infection of mouth)
  6. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  7. Pneumonia
  8. Pregnancy
  9. Premature delivery
  10. Aphasia (damage to the parts of the brain that control language)

male:

  1. Diabetes mellitus inadequate control
  2. Diabetic nephropathy (diabetic kidney disease)
  3. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  4. Diabetic retinopathy (damage to the retina caused by complications of diabetes)

What are the common drug interactions of Nicotine and Levemir, by age (0-1 to 60+)? *:

0-1:

  1. Foetal disorder (fetus disease)
  2. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  3. Low birth weight baby
  4. Premature baby

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Hypertension (high blood pressure)
  2. Neuropathy peripheral (surface nerve damage)
  3. Oral candidiasis (fungal infection of mouth)
  4. Peripheral arterial occlusive disease (reproducible ischemic muscle pain)
  5. Pneumonia
  6. Cardiac failure acute
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Diabetes mellitus inadequate control
  9. Diabetic nephropathy (diabetic kidney disease)
  10. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)

50-59:

  1. Aphasia (damage to the parts of the brain that control language)
  2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  3. Grand mal convulsion (a type of generalized seizure that affects the entire brain)

60+:

n/a

What are the existing conditions these people have? *

  1. Type 2 Diabetes: 4 people, 30.77%
  2. Normochromic Normocytic Anaemia (forms of anaemia in which the average size and haemoglobin content of the red blood cells are within normal limits): 4 people, 30.77%
  3. Hypokalemia (low potassium): 4 people, 30.77%
  4. High Blood Pressure: 4 people, 30.77%
  5. Diabetic Neuropathy (neuropathic disorders that are associated with diabetes mellitus): 4 people, 30.77%
  6. Constipation: 4 people, 30.77%
  7. Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 4 people, 30.77%
  8. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 15.38%
  9. Sleep Disorder: 1 person, 7.69%
  10. Pain: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Nicotine and Levemir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Nicotine and Levemir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Nicotine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Levemir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nicotine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Levemir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on nicotine and insulin detemir recombinant (the active ingredients of Nicotine and Levemir, respectively), and Nicotine and Levemir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: